<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
  xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
  xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://researchpepnews.com/articles/glp1-addiction-alcohol-drug-cravings</loc>
    <news:news>
      <news:publication>
        <news:name>Research Pep News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-02</news:publication_date>
      <news:title>Could Semaglutide, Tirzepatide and Retatrutide Quiet Alcohol and Drug Cravings?</news:title>
    </news:news>
    <image:image>
      <image:loc>https://researchpepnews.com/images/editorial/glp1-addiction-reward-circuit.png</image:loc>
      <image:caption>Researchers are testing whether incretin-based peptides can reduce the pull of alcohol and other addictive substances by changing cue- and reward-related signaling. Image: Research Pep News.</image:caption>
    </image:image>
  </url>
</urlset>